- Rituximab maintenance treatment of relapsed/resistant follicular non-…
Number of the records: 1  

Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study

  1. Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study / van Oers M. H. ... [et al.]. Onkológia Roč. 6, č. 1 (2011), s. 58
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all